Summary

Symptoms of cardiotoxicity resulting from cancer therapy, sometimes manifesting years or even decades later, are a problem for survivors. In a special session on cardio-oncology, expert consensus recommendations from the European Association of Cardiovascular Imaging on best practices for detecting signs of cardiotoxicity in cancer survivors were reviewed.